ClinicalTrials.govpublic full text
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
esophageal cancer, nimotuzumab, chemoradiotherapy, chemotherapy, immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836922
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.